Superficial basal cell carcinoma on face treated with 5% imiquimod cream.
Imiquimod, an immune response modifier, is known to possess both anti-viral and anti-tumor effect. We report our experience of treating a large superficial spreading basal cell carcinoma with 5% imiquimod cream. A 65-year-old male had an asymptomatic, hyperpigmented, slowly progressive, indurated, 3 x 4 cm plaque on the left cheek for two months. Biopsy from the lesion showed features of basal cell carcinoma. The patient was treated with imiquimod 5% cream, topically three times a week for six months with complete resolution of the lesion and without any side-effects. There was no clinical or histological recurrence after three months of stopping the treatment.
Malhotra
Amit Kumar
AK
Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi--110 029, India.
Bansal
Arika
A
Mridha
Asit R
AR
Khaitan
Binod K
BK
Verma
Kaushal K
KK
D000368:Aged; D000634:Aminoquinolines / Q000008:administration & dosage*; D002280:Basal Cell Carcinoma / Q000175:diagnosis / Q000188:drug therapy*; D005145:Face / Q000473:pathology; D006801:Humans; D000077271:Imiquimod; D008297:Male; D009824:Ointments; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*
D000634:Aminoquinolines; D009824:Ointments; D000077271:Imiquimod